×
0 0.0112519584104829 0.0112519584104829 0.0395954992166357 0.068081469876086 0.0253525138869106 0.0539809143996581 0.295969235151688
Stockreport

Auris Medical to provide update on intranasal betahistine program on October 17; shares up 10% premarket [Seeking Alpha]

AURIS MEDICAL HOLDING AG COMMON (EARS)  More Company Research Source: Seeking Alpha
Last auris medical holding ag common earnings: 8/10 06:31 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aurismedical.com
PDF Auris Medical Holding AG (NASDAQ: EARS ) will hold a conference call on Wednesday, October 17 at 8:00 am ET (2:00 pm CET) to provide update on its intranasal betahistine program, including key results from the second Phase 1 trial. Shares are up   premarket. See all stocks on the move » Now read: AcelRx shares halted pending today's Ad Com vote on Dsuvia » Subscribe for full text news in your inbox [Read more]

IMPACT SNAPSHOT EVENT TIME: EARS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
EARS alerts
from News Quantified
Opt-in for
EARS alerts

from News Quantified
Opt-in for
EARS alerts

from News Quantified